Trial Profile
A pilot study to evaluate the adrenal response and outcomes in patients with cardiogenic shock after acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Tetracosactide (Primary)
- Indications Cardiogenic shock; Myocardial infarction
- Focus Therapeutic Use
- 04 Dec 2015 New trial record